KoelewijnJMVrijkotteTGMde HaasMvan der SchootCEBonselGJ.Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. BJOG. 2009;116(5):655-664.
3.
MakrooRGuptaRBhatiaARosammaNL.Rh phenotype, allele and haplotype frequencies among 51,857 blood donors in North India. Blood Transfus. 2014;12(1):36-39.
ThakralBAgrawalSKDhawanHKSalujaKDuttaSMarwahaN.First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers. Hematology. 2007;12(5):377-380.
KemperARNewmanTBSlaughterJL, et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022;150(3):e2022058859. doi:10.1542/peds.2022-058859
WhiteJQureshiHMasseyE, et al. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med. 2016;26(4):246-263. doi:10.1111/tme.12299
10.
KoelewijnJMVrijkotteTGMvan der SchootCEBonselGJde HaasM.Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008;48(5):941-952.
11.
SmithHMShireyRSThomanSKJacksonJB.Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology. 2013;29(4):127-130.
12.
PalMWilliamsB.Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pathology. 2015;47(2):151-155.